Enanta Pharmaceuticals
ENTA
ENTA
197 hedge funds and large institutions have $1.42B invested in Enanta Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 77 increasing their positions, 63 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
2% more funds holding
Funds holding: 193 → 197 (+4)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
19% less capital invested
Capital invested by funds: $1.75B → $1.42B (-$328M)
Holders
197
Holding in Top 10
2
Calls
$7.51M
Puts
$6.18M
Top Buyers
| 1 | +$36.7M | |
| 2 | +$28.4M | |
| 3 | +$28.2M | |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$18M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$17.7M |
Top Sellers
| 1 | -$31.1M | |
| 2 | -$17.7M | |
| 3 | -$7.07M | |
| 4 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$5.82M |
| 5 |
Two Sigma Investments
New York
|
-$5.7M |